Izabela TworowskaChief Scientific Officer at RADIOMEDIX, Inc., USASpeaker
Agenda Sessions
Development of Pb212 -Labelled Radiotherapeutics for Targeted Alpha-Emitter Therapy
, 11:35amView Session